Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 826 AL 840

Early Use of 60 Hz Frequency Subthalamic Stimulation in Parkinson's Disease: A Case Series and Review

Ramdhani RA, Patel A, Swope D, Kopell BH.

Neuromodulation. 2015 Dec;18(8):664-9. doi: 10.1111/ner.12288. Epub 2015 Apr 1.

Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF

Fischer R, Maier O.

Oxid Med Cell Longev. 2015;2015:610813. doi: 10.1155/2015/610813. Epub 2015 Mar 5.

New and emerging treatments for Parkinson disease

Fung VS.

Med J Aust. 2015 Apr 6;202(6):283-4. doi: 10.5694/mja15.00155.

An unusual neurological complication from a garden-variety organism: post-melioidosis parkinsonism

Ng CS, Azmin S, Law ZK, Sahathevan R, Wan Yahya WN, Remli R, Periyasamy P, Mohd Ibrahim N, Tan HJ.

Med J Aust. 2015 Apr 6;202(6):333-4. doi: 10.5694/mja14.00229.

Recent progress in drug discovery for Parkinson's disease

Gilligan PJ.

Curr Top Med Chem. 2015;15(10):905-7. doi: 10.2174/156802661510150328222828.

Dopamine D3 agonists in the treatment of Parkinson's disease

Das B, Modi G, Dutta A.

Curr Top Med Chem. 2015;15(10):908-26. doi: 10.2174/156802661510150328223428.

Inhibitors of leucine-rich repeat kinase 2 (LRRK2): progress and promise for the treatment of Parkinson's disease

Gilligan PJ.

Curr Top Med Chem. 2015;15(10):927-38. doi: 10.2174/156802661510150328223655.

Agonists of the tissue-protective erythropoietin receptor in the treatment of Parkinson's disease

Punnonen J, Miller JL, Collier TJ, Spencer JR.

Curr Top Med Chem. 2015;15(10):955-69. doi: 10.2174/156802661510150328224527.

Acute hyperkinetic syndrome due to ephedrone abuse

Dolgan A, Budrewicz S, Koszewicz M, Bladowska J, Slotwinski K, Zagrajek M, Koziorowska-Gawron E, Podemski R.

J Addict Med. 2015 May-Jun;9(3):244-5. doi: 10.1097/ADM.0000000000000048.

The effects of neuropeptide urocortin 2 on the spontaneous discharge and glutamatergic neurotransmission of striatum neurons

Liu C, Liu X, Song F, Li J, Zhang X, Yang J.

Neuropeptides. 2015 Apr;50:17-21. doi: 10.1016/j.npep.2015.03.001. Epub 2015 Mar 12.

Neurodegenerative diseases: expanding the prion concept

Walker LC, Jucker M.

Annu Rev Neurosci. 2015 Jul 8;38:87-103. doi: 10.1146/annurev-neuro-071714-033828. Epub 2015 Mar 30.

The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions

Bagga V, Dunnett SB, Fricker RA.

Behav Brain Res. 2015 Jul 15;288:107-17. doi: 10.1016/j.bbr.2015.03.058. Epub 2015 Apr 2.

A Strange Case of Downward Displacement of a Deep Brain Stimulation Electrode 10 Years Following Implantation: The Gliding Movement of Snakes Theory

Iacopino DG, Maugeri R, Giugno A, Giller CA.

World Neurosurg. 2015 Aug;84(2):591.e1-5. doi: 10.1016/j.wneu.2015.03.047. Epub 2015 Apr 1.

Translational research for Parkinson׳s disease: The value of pre-clinical primate models

Aron Badin R, Vadori M, Cozzi E, Hantraye P.

Eur J Pharmacol. 2015 Jul 15;759:118-26. doi: 10.1016/j.ejphar.2015.03.038. Epub 2015 Apr 2.

Distinct role of hydration water in protein misfolding and aggregation revealed by fluctuating thermodynamics analysis

Chong SH, Ham S.

Acc Chem Res. 2015 Apr 21;48(4):956-65. doi: 10.1021/acs.accounts.5b00032. Epub 2015 Apr 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias